Lupin Ltd has received final USFDA approval for its generic version of Dovonex scalp solution used in treatment of psoriasis of scalp. The drug calcipotriene topical solution is for strength of 0.005 per cent (scalp solution) and it is the generic equivalent of Dovonex scalp solution of Lep Pharmaceutical Products Ltd. It is used for topical treatment of chronic, moderately severe psoriasis of the scalp. According to industry estimates, Calcipotriene topical solution had annual sales of USD 5.9 million for 10 months
Company Profile : Lupin Ltd
Leave a Reply